Medical Research 101

𝐀𝐧𝐭𝐢𝐦𝐢𝐜𝐫𝐨𝐛𝐢𝐚𝐥 𝐒𝐮𝐬𝐜𝐞𝐩𝐭𝐢𝐛𝐢𝐥𝐢𝐭𝐲 𝐓𝐞𝐬𝐭𝐢𝐧𝐠 𝐌𝐚𝐫𝐤𝐞𝐭 𝐰𝐨𝐫𝐭𝐡 $𝟓.𝟔𝟖 𝐁𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 𝟐𝟎𝟐𝟗 𝑫𝒐𝒘𝒏𝒍𝒐𝒂𝒅 𝑷𝑫𝑭 𝑩𝒓𝒐𝒄𝒉𝒖𝒓𝒆>> bit.ly/4htNzsa The global antimicrobial susceptibility testing market is expected to reach 5.68 billion by 2029 from USD 4.45 billion in 2024, growing at a CAGR of 5.0%. bioMérieux Becton, Dickinson and Company Thermo Fisher Scientific Danaher Corporation Bio-Rad Laboratories Bruker Merck KGaA, Darmstadt, Germany Roche Diagnostics UK & Ireland Accelerate Diagnostics HiMedia Laboratories Pvt. Ltd. LIOFILCHEM S.R.L. ALIFAX S.R.L. Creative Diagnostics Synbiosis Bioanalyse ZHUHAI DL Biotech CO., Ltd. ELITechGroup - A Bruker Company Mast Group Ltd Condalab GeneFluidics Biotron Healthcare (India) Pvt. Ltd InvivoGen MP Biomedicals QuantaMatrix Sysmex Europe COPAN Diagnostics, Inc. ERBA Diagnostics, Inc.

𝐄𝐩𝐢𝐠𝐞𝐧𝐞𝐭𝐢𝐜𝐬 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐰𝐨𝐫𝐭𝐡 $𝟒.𝟑 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 𝟐𝟎𝟐𝟖, 𝐰𝐢𝐭𝐡 𝐚 𝐂𝐀𝐆𝐑 𝐨𝐟 𝟏𝟖.𝟑% 𝑫𝒐𝒘𝒏𝒍𝒐𝒂𝒅 𝑷𝑫𝑭 𝑩𝒓𝒐𝒄𝒉𝒖𝒓𝒆: bit.ly/3UBiXLC The global epigenetics market growth forecasted to transform from USD 1.8 billion in 2023 to USD 4.3 billion by 2028, driven by a CAGR of 18.3%. 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞: Eurofins Scientific Finland Oy Thermo Fisher Scientific Pace® Analytical Services INTERTEK GROUP PLC IQVIA. Merck KGaA, Darmstadt, Germany Source BioScience Almac Group Laboratory Corporation of America Holdings SGS Life Science Services, S.A. Charles River Laboratories WuXi AppTec Element Materials Technology ICON plc Frontage Laboratories, Inc STERIS Sartorius ALS Life Sciences Syneos Health Medpace LGC PAREXEL International (UK) Limited Celerion Pharmaron BioAgilytix

𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐀𝐧𝐚𝐥𝐲𝐭𝐢𝐜𝐚𝐥 𝐓𝐞𝐬𝐭𝐢𝐧𝐠 𝐒𝐞𝐫𝐯𝐢𝐜𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐰𝐨𝐫𝐭𝐡 $𝟏𝟐.𝟔 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 𝟐𝟎𝟐𝟗 𝑫𝒐𝒘𝒏𝒍𝒐𝒂𝒅 𝑷𝑫𝑭 𝑩𝒓𝒐𝒄𝒉𝒖𝒓𝒆>> bit.ly/4e9rXhW The global size of healthcare analytical testing services market in terms of revenue was estimated to be worth $7.4 billion in 2024 and is poised to reach $12.6 billion by 2029, growing at a CAGR of 11.2% from 2024 to 2029. Eurofins Scientific Finland Oy Thermo Fisher Scientific Pace® Analytical Services INTERTEK GROUP PLC IQVIA Merck Group Source BioScience Almac Group Laboratory Corporation of America Holdings SGS Life Science Services, S.A. Charles River Laboratories WuXi AppTec. Element Materials Technology ICON plc Frontage Laboratories, Inc STERIS Sartorius ALS Life Sciences Syneos Health Medpace LGC PAREXEL International (UK) Limited Celerion Pharmaron BioAgilytix Labs, LLC

𝐀𝐝𝐯𝐚𝐧𝐜𝐞𝐝 𝐕𝐢𝐬𝐮𝐚𝐥𝐢𝐳𝐚𝐭𝐢𝐨𝐧 𝐌𝐚𝐫𝐤𝐞𝐭 𝐰𝐨𝐫𝐭𝐡 $𝟔.𝟓𝟓 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 𝟐𝟎𝟐𝟗 𝑫𝒐𝒘𝒏𝒍𝒐𝒂𝒅 𝑷𝑫𝑭 𝑩𝒓𝒐𝒄𝒉𝒖𝒓𝒆 @ https://lnkd.in/dAfkyvEa The global advanced visualization market is expected to reach USD 6.55 billion by 2029 from USD 3.78 billion in 2024, at a CAGR of 11.7% during the forecast period. Agfa-Gevaert S.A. Canon Medical Systems Corporation FUJIFILM Holdings Corporation GE HealthCare Koninklijke Kentalis Siemens Healthineers Stryker Change Healthcare TeraRecon, Inc.  Ziosoft Pro Medicus Limited Carestream Fovia Ai, Inc. 4DMedical Synopsys Inc Novarad AnalyzeDirect Syntermed, Inc Pie Medical Imaging INFINITT Healthcare Biotronics3D Ltd MiNNOVAA PostDICOM CitiusTech Ceevra, Inc. CitiusTech Ceevra, Inc. Sectra

𝐔𝐥𝐭𝐫𝐚𝐬𝐨𝐮𝐧𝐝 𝐍𝐞𝐞𝐝𝐥𝐞 𝐆𝐮𝐢𝐝𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐰𝐨𝐫𝐭𝐡 $𝟑𝟔𝟗 𝐦𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 𝟐𝟎𝟐𝟕 𝑫𝒐𝒘𝒏𝒍𝒐𝒂𝒅 𝑷𝑫𝑭 𝑩𝒓𝒐𝒄𝒉𝒖𝒓𝒆 @ https://lnkd.in/dkWC6EJc The global ultrasound needle guides market in terms of revenue was estimated to be worth $274 million in 2022 and is poised to reach $369 million by 2027, growing at a CAGR of 6.1% from 2022 to 2027. The APAC market is expected to grow at the highest rate during the forecast period. Factors such as the rising prevalence of target diseases, and the ongoing trend of device miniaturization. However, factors such as the stringent government regulations related to the OB/GYN applications of ultrasound, limited availability of medical reimbursements for ultrasound, and the shortage of trained and skilled sonographers are expected to hamper the growth of the Asia Pacific ultrasound needle guides market during the forecast period. Roper Technologies, Inc. Aspen Surgical FUJIFILM Holdings Corporation Siemens Healthineers Becton, Dickinson and Company Argon Medical Devices, Inc. Hologic, Inc. Remington Medical Inc. GEOTEK MEDICAL LTD InnoFine Medical | Ultrasound Needle Guides KOELIS Rocket Medical BIRR BioSciences IZI Medical Sheathing Technologies, Inc weLLgo Medical Products Advance Medical Designs

𝐀𝐥 𝐢𝐧 𝐁𝐢𝐨𝐭𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐰𝐨𝐫𝐭𝐡 $𝟕.𝟕𝟓 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 𝟐𝟎𝟐𝟗 𝑫𝒐𝒘𝒏𝒍𝒐𝒂𝒅 𝑷𝑫𝑭 𝑩𝒓𝒐𝒄𝒉𝒖𝒓𝒆>> https://lnkd.in/dh2Kni6X The global AI in biotechnology market is projected to reach USD 7.75 billion by 2029 from USD 3.23 billion in 2024, at a high CAGR of 19.1% during the forecast period. In 2023, North America held the largest share of the AI in biotechnology market. The region has favourable regulatory frameworks from agencies such as the FDA that encourage the adoption of AI in biopharma, allowing for accelerated approvals for AI-assisted diagnostics and therapies. and the North America holds many biotech start-ups mostly in the US. Huge innovation and collaboration are prevailing in the areas that lead to tremendous advancement in AI application. Nvidia Corporation Illumina Exscientia Schrödinger Recursion SOPHiA GENETICS Predictive Oncology. Deep Genomics. Data4Cure, Inc. GENOOX BenevolentAI DNAnexus Tempus AI NuMedii XtalPi Inc. Lifebit Biotech BPGbio, Inc., Valo Health VeriSIM Life iktos. Insilico Medicine Eurofins Discovery. Logica. American Chemical Society Aganitha

𝐏𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐜𝐚𝐥 𝐃𝐫𝐲𝐢𝐧𝐠 𝐄𝐪𝐮𝐢𝐩𝐦𝐞𝐧𝐭 𝐌𝐚𝐫𝐤𝐞𝐭 𝐰𝐨𝐫𝐭𝐡 $𝟖.𝟏𝟖 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 𝟐𝟎𝟐𝟗 𝑫𝒐𝒘𝒏𝒍𝒐𝒂𝒅 𝑷𝑫𝑭 𝑩𝒓𝒐𝒄𝒉𝒖𝒓𝒆>> bit.ly/48lGF4b The global pharmaceutical drying equipment market is projected to reach USD 8.18 billion by 2029 from USD 5.80 billion in 2024, at a CAGR of 7.1% during the forecast period. GEA Group ATS Corporation Hosokawa Micron Limited Freund I.M.A. Industria Macchine Automatiche S.p.A. Makat Candy Technology GmbH a Syntegon company BUCHI Laboratory Equipment OPTIMA packaging group MechaTech Systems Ltd BEW Engineering Limited Zirbus technology GmbH SPX FLOW, Inc. European SprayDry Technologies Yamato Scientific Co., Ltd. SAKA Engineering Systems Private Limited SPX FLOW, Inc. ilShin BioBase Europe B.V. Okawara Mfg. Co., Ltd. Changzhou Changjiang Drying equipment Co., ltd. BACHILLER Millrock Technology. Martin Christ Gefriertrocknungsanlagen GmbH Labconco Corporation O'Hara Technologies Inc. Coolvacuum  Shachi Engineering Pvt. Ltd.

𝐏𝐚𝐫𝐭𝐢𝐜𝐥𝐞 𝐒𝐢𝐳𝐞 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐰𝐨𝐫𝐭𝐡 $𝟓𝟗𝟔 𝐦𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 𝟐𝟎𝟐𝟖 𝑫𝒐𝒘𝒏𝒍𝒐𝒂𝒅 𝑷𝑫𝑭 𝑩𝒓𝒐𝒄𝒉𝒖𝒓𝒆: bit.ly/40iEsV9 The global particle size analysis market in terms of revenue was estimated to be worth $446 million in 2023 and is poised to reach $596 million by 2028, growing at a CAGR of 6.0% from 2023 to 2028. North America, comprising the US and Canada, accounted for the largest market share of the particle size analysis market in 2022. The North American region is experiencing growth in the particle size analysis market due to factors Rising nanotechnology awareness, the presence of major nanotechnology companies in North America, government reforms and regulations to improve product quality, high industry standards, and the gradual shift of manufacturing and pharmaceutical R&D from developed markets to the United States are fueling the growth of the North American particle size analysis market. 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞: Spectris plc HORIBA Danaher Corporation Anton Paar Bettersize Instruments Brookhaven Instruments Fritschle GmbH LS Instruments Micromeritics Instrument Corporation Microtrac Retsch GmbH SHIMADZU CORPORATION Sympatec GmbH - System | Partikel | Technik TSI Group PAMAS Partikelmess- und Analysesysteme GmbH Jinan Winner Particle Instrument Stock Co ,.ltd 3P Instruments Izon Science CSC Scientific Company, Inc. InProcess-LSP Yokogawa Fluid Imaging Technologies APIX Analytics Genizer Technovalue

𝐂𝐚𝐭𝐭𝐥𝐞 & 𝐏𝐨𝐫𝐜𝐢𝐧𝐞/𝐒𝐰𝐢𝐧𝐞 𝐑𝐞𝐩𝐫𝐨𝐝𝐮𝐜𝐭𝐢𝐯𝐞 𝐃𝐢𝐬𝐞𝐚𝐬𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐰𝐨𝐫𝐭𝐡 $𝟗𝟕𝟓.𝟖 𝐦𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 𝟐𝟎𝟐𝟗 𝑫𝒐𝒘𝒏𝒍𝒐𝒂𝒅 𝑷𝑫𝑭 𝑩𝒓𝒐𝒄𝒉𝒖𝒓𝒆>> bit.ly/3A0vbqd The global cattle & porcine/swine reproductive diseases market is projected to grow from USD 758.2 million in 2024 to USD 975.8 million by 2029, at a CAGR of 5.2% during the forecast period. Zoetis Merck Group Boehringer Ingelheim Virbac Elanco (Shanghai) Animal Health Co Ltd Vetoquinol Saúde Animal. Ceva Santé Animaleé IDEXX LABORATORIES LIMITED Thermo Fisher Scientific BioChek Ring Biotechnology Co Ltd Sequent Scientific Limited HIPRA QIAGEN Innovative Diagnostics Colorado Serum Company, Inc. Indian Immunologicals Limited Refit Animal Care Calier Megacor Diagnostik GmbH Vetanco Brasil Biogénesis Bagó AdvaCare Pharma USA BioX Diagnostics Pax Healthcare

𝐎𝐫𝐚𝐥 𝐏𝐫𝐨𝐭𝐞𝐢𝐧𝐬 & 𝐏𝐞𝐩𝐭𝐢𝐝𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐰𝐨𝐫𝐭𝐡 $𝟐𝟎.𝟑𝟔 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 𝟐𝟎𝟐𝟗 𝑫𝒐𝒘𝒏𝒍𝒐𝒂𝒅 𝑷𝑫𝑭 𝑩𝒓𝒐𝒄𝒉𝒖𝒓𝒆 @ bit.ly/3BWwzdQ The market for oral proteins and peptides is projected to reach USD 20.36 billion by 2029 from USD 7.38 billion in 2024, at a CAGR of 22.5% from 2024 to 2029. North America was the largest segment of the oral proteins and peptides market in 2023, followed by Europe and the Asia Pacific. The presence of key market players such as AbbVie (US) & Pfizer (US), the increasing approval of oral proteins and peptide products in North America, the availability of government funding for life science research, advances in drug delivery techniques, and growth in the pharmaceutical & biopharmaceutical industries have made North America the largest regional market for oral proteins and peptides. Novo Nordisk Pharmatech A/S AbbVie. PFIZER INC. Acadia Pharmaceuticals Inc. Aurinia Pharmaceuticals Inc. Bausch Health Companies Inc. CHIESI FARMACEUTICI S.P.A. Entera Bio Ltd. Merck Group Johnson & Johnson R-Pharm Proxima Concepts Limited SWK Holdings Corporation AstraZeneca Regor Therapeutics Group Viking Therapeutics, Inc. Protagonist Therapeutics Rani Therapeutics Carmot Therapeutics, Inc. Terns Pharmaceuticals Structure Therapeutics Zealand Pharma Sciwind Biosciences Jiangsu HENGRUI Biology Chemical Co., ltd.